This post was updated Nov. 20 at 7:47 p.m. A University of California professor and co-originator of genome editing technology Clustered Regularly Interspaced Short Palindromic Repeats said ...

Nobel Prize winner Jennifer Doudna, who co-invented CRISPR-Cas9 genome editing technology, joined President Christina Paxson P’19 for a virtual conversation on CRISPR’s wide-ranging applications and ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Zebrafish—small, fast-growing creatures who share many of the same genes as humans—are instrumental to many biologists, who find them uniquely well suited for studying a wide range of questions, from ...

Scientists launch company to develop the therapeutic potential of gene-snipping enzymes. You have full access to this article via your institution. Instead of taking prescription pills to treat their ...

CRISPR excites ambition. Just consider a few CRISPR applications: gene drives (showing promise as a way to prevent malaria); ex vivo and in vivo gene therapies (entering clinical trials); and ...

A powerful new gene-editing technology called CRISPR has enormous potential to treat human diseases but the ability to tinker with genes can also be controversial. Here we explain what CRISPR is and ...

Jennifer Doudna, a professor of chemistry and of biochemistry and molecular biology at the University of California, Berkeley known for co-discovering the CRISPR-Cas9 genome-editing technology, gave ...